APPLICATION
NDA210884
TYPE
NDA
ORIGINAL APPROVAL
2019-01-25
LATEST ACTION
2019-01-25
ROUTE
NASAL
DOSAGE FORM
SPRAY
MARKETING STATUS
Prescription
Products
TOSYMRA · ReferencePrescription
SUMATRIPTAN 10MG/SPRAY · SPRAY · NASAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.